A new vaccine for glioblastoma brain cancer suspends tumor growth and is well tolerated by patients, according to the results of an early phase clinical trial.
A new clinical trial will test whether an experimental vaccine can help patients' immune systems to stop the spread of deadly glioblastoma brain cancer.
